ArticleUpdates in surgery2026
Minimally invasive total pharyngo-laryngo-esophagectomy as a salvage procedure, technical notes and outcomes from a multidisciplinary team approach.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Total pharyngo-laryngo-esophagectomy (TPLE) represents the main salvage surgical procedure for cervical oesophageal cancer involving the hypopharynx after failed definitive chemoradiation (CRT). It is an extremely extensive, technically challenging, and high-risk procedure. We report a series of totally minimally invasive transthoracic TPLEs with gastric pull-up reconstruction in a referral center for esophageal surgical oncology. We retrospectively reviewed medical records of all patients undergoing TPLE in our institution from January 2018 to March 2024 from a prospectively collected database. The operations were performed by two teams of esophagogastric surgeons and otolaryngology head and neck surgeons. Fourteen patients underwent TPLE during the study period. Indications were salvage surgery for squamous cell carcinoma (SCC) of the cervical esophagus involving the hypopharynx, which was persistent/recurrent after CRT in 10 patients (71.4%) and a second primary tumour in 3 patients (21.4%), and surgery for thyroid cancer involving the larynx and the cervical esophagus in one case (7%). Median age at surgery was 64 years (range 41–80). In-hospital mortality was 0%, major complications rate (Clavien-Dindo ≥ 3a) was 43%, anastomotic leak rate occurred in 3 patients (21.4%), mean length of hospital stay was 36 days (17–86). Eight patients (57.1%) were alive and disease free with a median follow-up time of 16 months (2–67). Salvage transthoracic totally minimally invasive TPLE, despite the high morbidity, is feasible and safe when performed by a multidisciplinary surgical team and can be curative for persistent or recurrent cancer of the pharyngoesophageal junction after definitive CRT.
Indexed as
Identifiers
41758289What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.